NeuroPace, Inc. (NPCE)
NASDAQ: NPCE · Real-Time Price · USD
17.04
+0.10 (0.59%)
At close: Jan 22, 2026, 4:00 PM EST
17.50
+0.46 (2.70%)
After-hours: Jan 22, 2026, 6:20 PM EST
NeuroPace Market Cap
NeuroPace has a market cap or net worth of $567.56 million as of January 22, 2026. Its market cap has increased by 59.39% in one year.
Market Cap
567.56M
Enterprise Value
578.73M
1-Year Change
59.39%
Ranking
Category
Stock Price
$17.04
Market Cap Chart
Since the IPO on April 22, 2021, NeuroPace's market cap has increased from $393.28M to $567.56M, an increase of 44.32%. That is a compound annual growth rate of 8.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 567.56M | 10.36% |
| Dec 31, 2025 | 514.27M | 53.97% |
| Dec 31, 2024 | 334.00M | 23.25% |
| Dec 29, 2023 | 270.98M | 630.30% |
| Dec 30, 2022 | 37.11M | -84.86% |
| Dec 31, 2021 | 245.09M | -37.68% |
| Apr 22, 2021 | 393.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Beta Bionics | 725.09M |
| Cytek Biosciences | 705.81M |
| Tactile Systems Technology | 681.46M |
| Standard BioTools | 630.69M |
| Avanos Medical | 596.95M |
| Varex Imaging | 593.16M |
| Orthofix Medical | 548.46M |
| Bioventus | 535.81M |